Several companies worldwide claim to possess the required expertise *Roots Analysis*

Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex manufacturing protocols; this is true for antibody-based products as well. Presently, there are a number of companies that claim to offer end-to-end solutions, ranging from antibody development to commercial production. Further, prevalent trends suggest that sponsor companies are likely to continue relying on contract service providers for various aspects of antibody-based product development and manufacturing.

 

To order this 285+ page report, which features 100+ figures and 110+ tables, please visit thishttps://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html

 

The USD 17 billion (by 2030) financial opportunity within the antibody contract manufacturing market has been analyzed across the following segments:

  • Type of Antibodies
  • Monoclonal Antibodies
  • Bispecific Antibodies
  • ADCs
  • Others

 

  • Company Size
  • Small
  • Mid-sized
  • Large / Very Large

 

  • Scale of Operation
  • Preclinical / Clinical
  • Commercial

 

  • Type of expression system used
  • Mammalian
  • Microbial

 

  • Key geographical regions
  • North America
  • Europe
  • Asia and RoW

 

The Antibody Contract Manufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain: 

  • AGC Biologics
  • Aldevron
  • AMRI
  • Boehringer Ingelheim BioXcellence
  • Emergent BioSolutions
  • Eurofins CDMO
  • FUJIFILM Diosynth Biotechnologies
  • KBI Biopharma
  • Lonza
  • Nitto Avecia Pharma Services
  • Novasep
  • Pierre Fabre
  • Samsung BioLogics
  • Synthon
  • Thermo Fisher Scientific

 

Table of Contents

 

  1. Preface

 

  1. Executive Summary

 

  1. Introduction

 

  1. Market Landscape

 

  1. Company Competitive Analysis

 

  1. Company Profiles

 

  1. Case Study: Comparison of Small and Large Molecules (Biologics) Drugs / Therapies

 

  1. Benchmark Analysis

 

  1. Partnerships

 

  1. Recent Expansions

 

  1. Capacity Analysis

 

  1. Demand Analysis

 

  1. Market Sizing and Opportunity Analysis

 

  1. SWOT Analysis

 

  1. Future of The Antibody CMO Market

 

  1. Interview Transcripts

 

  1. Appendix 1: List of Antibody Custom Manufacturers

 

  1. Appendix 2: Tabulated Data

 

  1. Appendix 3: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com